Walter Klemp - Autonomix Medical, Executive Chairman
| AMIX Stock | 3.15 0.20 5.97% |
Chairman
Walter Klemp is Executive Chairman of Autonomix Medical, Common
| Age | 64 |
| Phone | 713 588 6150 |
| Web | https://autonomix.com |
Walter Klemp Latest Insider Activity
Tracking and analyzing the buying and selling activities of Walter Klemp against Autonomix Medical, stock is an integral part of due diligence when investing in Autonomix Medical,. Walter Klemp insider activity provides valuable insight into whether Autonomix Medical, is net buyers or sellers over its current business cycle. Note, Autonomix Medical, insiders must abide by specific rules, including filing SEC forms every time they buy or sell Autonomix Medical,'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Walter Klemp 23 hours ago Disposition of 56250 shares by Walter Klemp of Moleculin Biotech subject to Rule 16b-3 | ||
Walter Klemp over a month ago Acquisition by Walter Klemp of 43590 shares of Moleculin Biotech subject to Rule 16b-3 | ||
Walter Klemp over three months ago Acquisition by Walter Klemp of 188404 shares of Moleculin Biotech at 0.69 subject to Rule 16b-3 | ||
Walter Klemp over three months ago Acquisition by Walter Klemp of 24742 shares of Moleculin Biotech at 1.0208 subject to Rule 16b-3 |
Autonomix Medical, Management Efficiency
The company has return on total asset (ROA) of (1.7647) % which means that it has lost $1.7647 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (270.1708) %, meaning that it created substantial loss on money invested by shareholders. Autonomix Medical,'s management efficiency ratios could be used to measure how well Autonomix Medical, manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Ron Yekutiel | Kaltura | 51 | |
Management Performance
| Return On Equity | -270.17 | ||||
| Return On Asset | -1.76 |
Autonomix Medical, Common Leadership Team
Elected by the shareholders, the Autonomix Medical,'s board of directors comprises two types of representatives: Autonomix Medical, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Autonomix. The board's role is to monitor Autonomix Medical,'s management team and ensure that shareholders' interests are well served. Autonomix Medical,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Autonomix Medical,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD, CoFounder Officer | ||
| Landy Toth, CoFounder Officer | ||
| Jennifer Cook, Chief Officer | ||
| Walter Klemp, Executive Chairman | ||
| Trent CPA, Chief Officer | ||
| Lori Bisson, Executive Chairman | ||
| Bradley Hauser, CEO President |
Autonomix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Autonomix Medical, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -270.17 | ||||
| Return On Asset | -1.76 | ||||
| Current Valuation | 2.17 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 27.20 % | ||||
| Shares Owned By Institutions | 8.67 % | ||||
| Number Of Shares Shorted | 36.62 K | ||||
| Price To Book | 1.96 X | ||||
| EBITDA | (15.27 M) | ||||
| Net Income | (15.43 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.